Search results
Results from the WOW.Com Content Network
Among common consequences of complete or nearly complete pancreatectomy are deficiencies of pancreatic endocrine or exocrine function requiring replacement of insulin or digestive enzymes. The patient immediately develops type 1 diabetes, with little hope for future type 1 diabetes treatments involving the restoration of endocrine function to a ...
Pancreatic leak or pancreatic fistula, defined as fluid drained after postoperative day 3 that has an amylase content greater than or equal to 3 times the upper limit of normal, occurs in 5–10% of operations, [31] [32] although changes in the definition of fistula may now include a much larger proportion of patients (upwards of 40%).
Pancreatic cancer rarely occurs before the age of 40, and more than half of cases of pancreatic adenocarcinoma occur in those over 70. [2] Risk factors for pancreatic cancer include tobacco smoking, obesity, diabetes, and certain rare genetic conditions. [2] About 25% of cases are linked to smoking, [3] and 5–10% are linked to inherited genes ...
Surgery can include the removal of the head of the pancreas (a pancreaticoduodenectomy), removal of the body and tail of the pancreas (a distal pancreatectomy), or rarely removal of the entire pancreas (a total pancreatectomy). [6] In selected cases the surgery can be performed using minimally invasive techniques such as laparoscopy. [7]
A pancreatic tumor is an abnormal growth in the pancreas. [1] In adults, almost 90% are pancreatic cancer and a few are benign. [1] Pancreatic tumors are rare in children. [1] Classification is based on cellular differentiation (ductal, acinar, neuroendocrine, other) and gross appearance (intraductal, cystic, solid). [1]
View my plan; Call live aol support at. 1-800-358-4860. Get live expert help with your AOL needs—from email and passwords, technical questions, mobile email and more.
AOL latest headlines, entertainment, sports, articles for business, health and world news.
At the time the Lustgarten Foundation was established, pancreatic cancer was an orphan disease, with less than one half of one percent of the total National Cancer Institute's budget supporting fewer than 15 researchers nationally. Because funding was so limited, it was difficult to find researchers to study the disease.